HOOKIPA Pharma Inc.
HOOK · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $5 | $1 |
| % Growth | 48% | -71.2% | 264.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $1 | $5 | $1 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $13 | $13 | $16 | $20 |
| G&A Expenses | $7 | $5 | $7 | $4 |
| SG&A Expenses | $7 | $5 | $7 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Expenses | $20 | $19 | $23 | $24 |
| Operating Income | -$18 | -$21 | -$19 | -$22 |
| % Margin | -891.9% | -1,584.9% | -396.4% | -1,740.9% |
| Other Income/Exp. Net | $2 | -$4 | $5 | $3 |
| Pre-Tax Income | -$15 | -$25 | -$14 | -$19 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$15 | -$25 | -$14 | -$19 |
| % Margin | -769.8% | -1,842.7% | -294.3% | -1,480.2% |
| EPS | -1.23 | -1.99 | -1.1 | -1.52 |
| % Growth | 38.2% | -80.9% | 27.6% | – |
| EPS Diluted | -1.23 | -1.99 | -1.1 | -1.52 |
| Weighted Avg Shares Out | 13 | 13 | 13 | 13 |
| Weighted Avg Shares Out Dil | 13 | 13 | 13 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$15 | -$24 | -$13 | -$18 |
| % Margin | -750.4% | -1,798.9% | -279.4% | -1,424.9% |